Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

  • Clinical Trials

    U.S. Clinical Trial Imaging Market Growth Forecast

    May 13th, 2024

    The U.S. clinical trial imaging market, valued at USD 409.50 million in 2023, is projected to reach USD 875.93 million by 2033 with a CAGR of 7.9% according to Nova One Advisor. Market growth is ultimately driven by increased pharmaceutical and biotechnology investments and rising R&D [...]

Latest Stories

HEOR

RWE

Market Access

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

05/13/2024 04:46 PM ET

AC Immune SA PRTA date announcement

Prothena Corporation plc already had five catalyst announcements coming up, but they added another one today. It plans to announce top-line results for their Phase 2/3 trial of NNC6019 (PRX004) on December 31, 2024. Currently, [...]

Read More
05/13/2024 04:46 PM ET

Alpha Tau Medical Ltd. DRTS results announcement

Alpha Tau Medical Ltd. provided an update to their Phase 1 trial for Alpha DaRT. Our analysts summarized the update as follows:

"First patient treated on May 13, 2024."

This is one of three upcoming [...]

Read More
05/13/2024 04:46 PM ET

Reviva Pharmaceuticals Holdings RVPH date announcement

Reviva Pharmaceuticals Holdings already had six catalyst announcements coming up, but they added another one today. It will be announcing top-line results for their recent Preclinical trial for Brilaroxazine on May 21, 2024. Our model [...]

Read More
05/13/2024 04:46 PM ET

Anebulo Pharmaceuticals JSPR results announcement

Jasper Therapeutics has provided investors an update on their recent Phase 1/2 trial for Briquilimab. The results are summarized below:

"Phase 1b/2a study announced May 13, 2024, with enrollment to begin in 4Q 2024."

The [...]

Read More

Search HealthEconomics.com

Throw in a keyword, research topic, disease model or technology of interest

Latest From Our Blog

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Quick Links

Our Company

Privacy Policy

Advertising & Marketing Services


ABOUT US

HealthEconomics.com is the world’s largest digital Connected Community™ for Value, Evidence and Access in the life sciences industry. HealthEconomics.com provides professionals within the health economic and outcomes research (HEOR), real-world evidence (RWE) and Market Access (MA) communities a single global link to industry insights and news, market reports and more. Since the beginning, we have provided unparalleled access to help our stakeholders drive business, improve knowledge and connect researchers and payer decision-makers worldwide.

SCIENTIST.COM FAMILY

Scientist.com is a privately-held, San Diego-based company on a mission to empower and connect scientists and make it faster and cheaper to discover new medicines. At its heart is an AI-powered marketplace for complex research experiments with the potential to transform the pharmaceutical industry in the same way Amazon has transformed the retail industry. The marketplace helps drug researchers use innovative technologies to rapidly translate their ideas into actionable data. Scientist.com’s clients include most of the world’s largest pharmaceutical companies, 100+ biotechs and the US National Institutes of Health. Through Scientist.com, these clients communicate directly with research experts at over 4,000 global laboratories to design and execute complex research experiments.

Learn more at Scientist.com.

© Copyright | HealthEconomics.Com - A Scientist.com Company | All Rights Reserved
LinkedInTwitterFacebookVimeo
Cookies help us deliver our services and optimize website experience. By continuing to browse this domain, you accept our terms and conditions and privacy policy. Read our privacy policy Accept
Go to Top